• About us
• Contact

Advertisement

Product › Details

Emadine®

	Next higher product group	emedastine (INN)
	Status	1999-01-27 registration start
	Organisation	Alcon Laboratories (UK) Ltd.
	Group	Novartis (Group)

Record changed: 2023-07-10

Advertisement

More documents for ophthalmic_o

• [1] Oculis Holding AG. (3/3/23). "Press Release: Oculis Announces US Public Listing on NASDAQ". Lausanne & Zug....
• [2] Amgen Inc.. (12/12/22). "Press Release: Rule 2.7 Announcement. Amgen Inc to Acquire Horizon Therapeutics plc". Thousand Oaks, CA....
• [3] Formycon AG. (8/29/22). "Press Release: European Commission Approves FYB201/Ranivisio (Ranivisio - Ranibizumab), a Biosimilar to Lucentis". Munich, Amsterdam & Zug....
• [4] Formycon AG. (8/3/22). "Press Release: U.S. Food and Drug Administration (FDA) Approved FYB201/Cimerli (ranibizumab-eqrn), the First and Only Biosimilar Interchangeable with Lucentis". Munich, Amsterdam & Zug....
• [5] Okyo Pharma Ltd.. (5/19/22). "Press Release: Okyo Pharma Limited Announces Closing of Public Offering and Nasdaq Listing". London....
• [6] Hovione. (5/9/22). "Press Release: Hovione and Jixing Announce an Exclusive Global License Agreement for Ophthalmology Program". Lisbon & Shanghai....
• [7] ProQR Therapeutics N.V.. (2/11/22). "Press Release: ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10". Leiden & Cambridge, MA....
• [8] Isarna Therapeutics GmbH. (9/30/21). "Press Release: Isarna Therapeutics Appoints Claus Schalper as CEO". Munich....
• [9] Visus Therapeutics Inc.. (8/10/21). "Press Release: Visus Therapeutics Secures $20 Million in Additional Financing Led by New Investor LSP, with Participation from Sage Partners". Seattle, WA....
• [10] Oxurion N.V.. (5/17/21). "Press Release: Oxurion NV Appoints Tom Graney, CFA as Chief Executive Officer. Patrik De Haes M.D. Becomes Non-executive Chairman". Leuven & Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.